Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing TrialsLisha Mou, Zuhui Pu, Bo Zhou et al.|Frontiers in Oncology|2021Cited by 74